Study on anti-HBV effect of total phenolics acid from Oenanthe Javanica in vitro and its mechanism
LIU Qingchuan1 WANG Panli2 YANG Xinbo1 WANG Renjie1 WANG Mengmeng1 HUANG Zhengming1
1.Beijing Weijian Jiye Institute of Biotechnology, Beijing 100039, China;
2.Department of Pharmacy, People′s Hospital of Shigatse, Tibet Autonomous Region, Xigaze 857000, China
Abstract:Objective To observe the inhibitory effect of total phenolics acid from Oenanthe Javanica on hepatitis B virus (HBV) in vitro and explore its mechanism. Methods The toxicity of total phenolics acid from Oenanthe Javanica to Hep AD38 cells was divided into the total phenolics acid from Oenanthe Javanica group (subdivided into 1600, 800, 400, 200, 100 μg/mL concentration groups) and the blank control group. Hep AD38 cells were cultured in vitro and the toxicity range of total phenolics acid from Oenanthe Javanica was determined by MTT assay. In vitro anti-HBV effects of total phenolics acid from Oenanthe Javanica were divided into the total phenolics acid from Oenanthe Javanica group (subdivided into 200, 100, 50 and 25 μg/mL concentration groups), the positive control group [Entecavir (ETV) 10 μmol/L] and the virus control group. Hep AD38 cells were treated with total phenolics acid from Oenanthe Javanica solution with a concentration below the non-toxic concentration for 6 consecutive days. The supernatant and cells were collected. The titer of HBsAg and HBeAg in the supernatant was detected by enzyme linked immune sorbent assay (ELISA). The intracellular HBV DNA load was detected by real-time fluorescent quantitative PCR. The effects of total phenolics acid from Oenanthe Javanica on duck hepatitis B virus (DHBV) DNA polymerase were divided into the total phenolics acid from Oenanthe Javanica group (subdivided into 400, 200, 100, 50 and 25 μg/mL concentration groups), the negative control group and the DHBV DNA polymerase control group. DHBV DNA polymerase was extracted from duck liver infected with duck hepatitis B virus, different concentrations of total phenolics acid from Oenanthe Javanica solution were given, and the effects of total phenolics acid from Oenanthe Javanica on DHBV DNA polymerase activity were detected by ELISA. Results The non-toxic concentration of total phenolics acid from Oenanthe Javanica in Hep AD38 cells was 400 μg/mL. Compared with the virus control group, HBsAg, HBeAg titer and HBV DNA load were significantly decreased in the 200, 100 and 50 μg/mL concentration groups of the total phenolics acid from Oenanthe Javanica group, the differences were highly statistically significant (P < 0.01). Compared with the DHBV DNA polymerase control group, DHBV DNA polymerase activity was inhibited in the 400, 200, and 100 μg/mL concentration groups of the total phenolics acid from Oenanthe Javanica group, the differences were highly statistically significant (P < 0.01). Conclusion Total phenolics acid from Oenanthe Javanicahas a good anti-HBV effect in vitro, and its mechanism includes inhibition of HBV DNA polymerase activity.
刘青川1 王盼丽2 杨新波1 王仁杰1 王蒙蒙1 黄正明1. 水芹总酚酸体外抗HBV作用及其机制探讨[J]. 中国医药导报, 2019, 16(28): 12-16,34.
LIU Qingchuan1 WANG Panli2 YANG Xinbo1 WANG Renjie1 WANG Mengmeng1 HUANG Zhengming1. Study on anti-HBV effect of total phenolics acid from Oenanthe Javanica in vitro and its mechanism. 中国医药导报, 2019, 16(28): 12-16,34.
[1] 黄正明,杨新波,曹文斌.水芹的本草考证[J].中草药,2001,32(1):59-62.
[2] 王选举,黄正明,杨新波,等.水芹总酚酸对2.2.15细胞HBV DNA、cccDNA的抑制作用[J].中国药理学通报,2009, 25(8):1099-1102.
[3] 王选举,黄正明,杨新波,等.水芹总酚酸对2.2.15细胞分泌HBsAg与HBeAg的抑制作用[J].解放军药学学报,2009,25(2):148-151.
[4] 王选举,黄正明,杨新波,等.水芹总酚酸对鸭乙肝病毒DNA的抑制作用[J].解放军药学学报,2009,25(6):501-505.
[5] Ai G,Huang ZM,Liu QC,et al. The protective effect of total phenolics from Oenanthe Javanica on acute liver failure induced by D-galactosamine [J]. J Ethnopharmacol,2016,186:53-60.
[6] 田丹,陈劲春,杨新波,等.水芹总酚酸胶囊质量控制方法的研究[J].解放军药学学报,2010,26(4):328-331.
[7] 赫晓林,黄建炜,许瑞安,等.HBV病毒复制机制及慢性乙型肝炎药物靶点[J].中国药理学通报,2015,31(2):152-156.
[8] Fukano K,Tsukuda S,Watashi K,et al. ConceptofViralInhibitorsviaNTCP [J]. Semin Liver Dis,2019,39(1):78-85.
[9] Tang L,Sheraz M,McGrane M,et al. DNA Polymerase alpha is essential for intracellular amplification of hepatitis B virus covalently closed circular DNA [J]. PLoS Pathog,2019,15(4):e1007742.
[10] 叶雨笙,朱紫衣,刘晨霞,等.红景天苷对HepG2.2.15细胞HBV DNA复制的影响及机制研究[J].安徽医科大学学报,2019,54(4):539-543.
[11] Li Y,Sun Y,Sun F,et al. Mechanisms and Effects on HBV Replication of the Interaction between HBV Core Protein and Cellular Filamin B [J]. Virol Sin,2018,33(2):162-172.
[12] King RW,Ladner SK. Hep AD38 Assay:A High-Throughput, Cell-Based Screen for the Evaluation of Compounds Against Hepatitis B Virus [J]. Methods Mol Med,2000, 24:43-50.
[13] Tang L,Zhao Q,Wu S,et al. The current status and future directions of hepatitis B antiviral drug discovery [J]. Expert Opin Drug Discov,2017,12(1):5-15.
[14] 王昕,白晓鹏,龙泉鑫.新型抗乙型肝炎病毒药物研发进展[J].国外医药:抗生素分册,2018,39(6):472-478.
[15] 沈国俊,江小云,黄洁,等.利用半肝切除再生模型研究单个肝细胞核内耐药鸭乙型肝炎病毒DNA的动态变化[J].临床肝胆病杂志,2017,33(11):2127-2131.
[16] 王群,杨朝国.T细胞免疫球蛋白黏蛋白分子3在乙型肝炎病毒感染慢性化中的作用机制[J].医学综述,2018,24(2):272-277.
[17] 冯静,张萍,邓菲,等.乙肝抗病毒药物苦参碱联合拉米夫定对乙肝病毒DNA聚合酶活性的影响[J].中药药理与临床,2017,33(6):89-92.
[18] 蒋莉,陈春华,濮翔科等.分析HBsAg与抗-HBs双阳患者血清模式与HBV DNA载量的临床意义[J].当代医学,2016,22(17):44-45.
[19] 王晋霞.HBV-DNA聚合酶对肝癌细胞恶性行为的调控及机制研究[D].天津:天津医科大学,2018.
[20] Odawara F,Abe H,Kohno T,et al. A highly sensitive chemiluminescent reverse transcriptase assay for human immunodeficiency virus [J]. J Virol Methods,2002,106(1):115-124.
[21] Wang J,Zhang L,Zhao J,et al. 2-Arylthio-5-iodo pyrimidine derivatives as non-nucleoside HBV polymerase inhibitors [J]. Bioorg Med Chem,2018,26(8):1573-1578.
[22] 王晨吟,刘青川,黄正明.水芹总酚酸对人类免疫缺陷病毒逆转录酶的抑制作用[J].中国医药导报,2013,10(12):4-5,8.
[23] 刘青川,王蒙蒙,艾国,等.水芹总酚酸对Fr.MuLV感染小鼠的抗病毒作用[J].解放军药学学报,2018,34(6):484-486.